[go: up one dir, main page]

NO953270L - Fibrinogenreceptorantagonister - Google Patents

Fibrinogenreceptorantagonister

Info

Publication number
NO953270L
NO953270L NO953270A NO953270A NO953270L NO 953270 L NO953270 L NO 953270L NO 953270 A NO953270 A NO 953270A NO 953270 A NO953270 A NO 953270A NO 953270 L NO953270 L NO 953270L
Authority
NO
Norway
Prior art keywords
fibrinogenreceptorantagonister
compounds
abncn
formula
receptor antagonist
Prior art date
Application number
NO953270A
Other languages
Norwegian (no)
Other versions
NO953270D0 (en
Inventor
David Alan Claremon
John J Baldwin
Nigel Liverton
Ben Askew
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO953270D0 publication Critical patent/NO953270D0/en
Publication of NO953270L publication Critical patent/NO953270L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Forbindelser ifølge oppfin- nelsen har formel (l) eller (2) O R2 R6 Q-(CH2)n-a-AB¿C-N-RS-C-R" m i- !,- O R2 R6 II l l Q-(CH2)n-a-AB¿C-Rs-c-R8 (2) R1 for eksempel (3). <w> (3) Forbindelsene har fibrinogenreseptor- antagonistaktivitet.Compounds of the invention have the formula (I) or (2) O R 2 R 6 Q - (CH 2) na-ABNCN-RS-CR AB¿C-Rs-c-R8 (2) R1 for example (3). <w> (3) The compounds have fibrinogen receptor antagonist activity.

NO953270A 1993-02-22 1995-08-21 Fibrinogenreceptorantagonister NO953270L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051793A 1993-02-22 1993-02-22
PCT/US1994/001881 WO1994018981A1 (en) 1993-02-22 1994-02-22 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
NO953270D0 NO953270D0 (en) 1995-08-21
NO953270L true NO953270L (en) 1995-10-19

Family

ID=21799049

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953270A NO953270L (en) 1993-02-22 1995-08-21 Fibrinogenreceptorantagonister

Country Status (15)

Country Link
EP (1) EP0684823A4 (en)
JP (1) JP3173792B2 (en)
KR (1) KR960700722A (en)
CN (1) CN1118139A (en)
AU (1) AU680240B2 (en)
BG (1) BG99863A (en)
CA (1) CA2155123A1 (en)
CZ (1) CZ210895A3 (en)
FI (1) FI953916A (en)
HU (1) HUT71796A (en)
NO (1) NO953270L (en)
NZ (1) NZ262664A (en)
PL (1) PL310386A1 (en)
SK (1) SK102495A3 (en)
WO (1) WO1994018981A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
IL123164A (en) * 1995-08-30 2001-03-19 Searle & Co Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
CA2233204A1 (en) 1995-09-29 1997-04-03 Joseph A. Jakubowski Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
WO1997023480A1 (en) * 1995-12-22 1997-07-03 The Du Pont Merck Pharmaceutical Company Novel integrin receptor antagonists
WO1997035579A1 (en) * 1996-03-27 1997-10-02 Merck & Co., Inc. A method for inhibiting clot formation
NZ333904A (en) * 1996-07-25 2000-06-23 Biogen Inc VLA-4 and IIb/IIIa cell adhesion inhibitors
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists
DE19653647A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin receptor antagonists, their preparation and their use
EP1023295A4 (en) * 1997-02-06 2001-01-24 Merck & Co Inc Fibrinogen receptor antagonist prodrugs
AU6780398A (en) * 1997-03-28 1998-10-22 Du Pont Merck Pharmaceutical Company, The Heterocyclic integrin inhibitor prodrugs
US6303625B1 (en) 1998-07-27 2001-10-16 Ortho-Mcneil Pharmaceutical, Inc. Triazolopyridines for the treatment of thrombosis disorders
CZ2002323A3 (en) * 1999-07-28 2002-05-15 Aventis Pharmaceuticals Products Inc. Substituted oxoazaheterocyclyl compounds and pharmaceutical preparations in which they are comprised
EP1572693A1 (en) * 2002-12-20 2005-09-14 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
US20100035756A1 (en) * 2006-07-12 2010-02-11 Syngenta Limited Triazolophyridine derivatives as herbicides
JP2011516498A (en) * 2008-04-04 2011-05-26 ギリアード サイエンシーズ， インコーポレイテッド Triazolopyridinone derivatives for use as inhibitors of stearoyl-CoA desaturase
WO2010096722A1 (en) * 2009-02-20 2010-08-26 Takeda Pharmaceutical Company Limited 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5166154A (en) * 1989-10-17 1992-11-24 Boehringer Ingelheim Pharmaceuticals, Inc. Imidazo[1,2-a]piperazines
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors

Also Published As

Publication number Publication date
AU6246594A (en) 1994-09-14
HUT71796A (en) 1996-02-28
CZ210895A3 (en) 1996-02-14
NZ262664A (en) 1997-04-24
AU680240B2 (en) 1997-07-24
FI953916A0 (en) 1995-08-21
WO1994018981A1 (en) 1994-09-01
JPH08507072A (en) 1996-07-30
NO953270D0 (en) 1995-08-21
KR960700722A (en) 1996-02-24
CA2155123A1 (en) 1994-09-01
SK102495A3 (en) 1997-01-08
BG99863A (en) 1996-02-29
EP0684823A1 (en) 1995-12-06
EP0684823A4 (en) 1997-07-09
HU9502028D0 (en) 1995-09-28
CN1118139A (en) 1996-03-06
JP3173792B2 (en) 2001-06-04
PL310386A1 (en) 1995-12-11
FI953916A (en) 1995-08-21

Similar Documents

Publication Publication Date Title
NO953270L (en) Fibrinogenreceptorantagonister
ATE100448T1 (en) SUBSTITUTED CHINAZOLINONES AS ANGIOTENSIN IIANTAGONISTS.
TR200101155T2 (en) 4-Aroil Piperidine CCR-3 Receptor Antagonists III
TR200101961T2 (en) 1,2-ring quinoline derivatives
EA200000098A1 (en) 4-AMINOPIRROL (3,2-d) Pyrimidine as antagonists of the neuropeptide Y neuropeptide
ATE37375T1 (en) PHOSPHONYL HYDROXYACYL AMINO ACID DERIVATIVES AND THEIR USE AS ANTIHYPERTENSIVES.
DE68925155D1 (en) Use of halogenated hydrocarbon solvent as a cleaning agent
MX9204661A (en) INTERMEDIATE COMPOUNDS DERIVED FROM ETER AND PROCEDURE FOR THE PREPARATION.
ATE203670T1 (en) USE OF ESTROGEN ANTAGONISTS AND AGONISTS TO INHIBIT PATHOLOGICAL CONDITIONS
NO971538L (en) Purine and guanine compounds as inhibitors of PNP
ATE206409T1 (en) N-(1-ALKYL-5-PHENYL-2,3,4,5-TETRAHYDRO-1-H-BENZO(B)(1,5)-DIAZEPINE-3-YL)-ACETAMIDE
FR2399430A1 (en) 1- (4-AMINO-6, 7-DIMETHOXY-2-QUINAZOLINYL) -4- (2-TETRAHYDROFUROYL) PIPERAZINE HYDROCHLORIDE DIHYDRATE, AND ITS USE AS ANTIHYPERTENSIFY AGENTS
ATE195737T1 (en) ANTAGONISTS OF THE FIBRINOGEN RECEPTOR
FI942457A (en) Preparation of substituted piperidines
DE69426452D1 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
NO972887L (en) Piperidinedacetic acid derivatives useful as fibrinogen antagonist agent
SE8500107L (en) NEW 8-ALFA-ACYLAMINOERGOLINE
TR200001222T2 (en) New tetracyclics, the process for their manufacture and pharmaceutical preparations containing these compounds.
NO954328D0 (en) Newly substituted 1-phenyl-pyridinyl-benzotriazoles
ES8701159A1 (en) N-(Aralkoxybenzyl)-4(benzhydryl) piperidines.
ES2062389T3 (en) SUBSTITUTED GLUTARAMIC ACIDS AND THEIR DERIVATIVES.
FI892222A (en) PEPTIDAL ALCOHOL WITH ANTICOAGULANT NETWORK.
DK365284A (en) 5-SUBSTITUTED (1,2,4) TRIAZOLO (1,5-C) PYRIMIDIN-2-AMINES
DE69827614D1 (en) quinoxalinediones
ATE119523T1 (en) ISOQUINOLINE DERIVATIVES AND THEIR SALTS AS PROTEASE INHIBITORS.